Tag: Imbruvica

Latest News

Janssen busca ampliar el uso de IMBRUVICA® (ibrutinib) en combinación con rituximab para pacientes con leucemia linfocítica crónica (LLC) no tratada con anterioridad

BEERSE, Bélgica–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson ha anunciado hoy la presentación de una solicitud de variación de Tipo II a la...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World